Search results
FTC Challenges Patents on 20 Brand-Name Drugs as Chair Accuses Them of Inflating Prices with 'Bogus'...
Homenewshere.com· 1 day agoThe Federal Trade Commission challenges patents on 20 brand-name drugs to spur competition, including the blockbuster weight-loss drug Ozempic. The FTC sent warning letters to 10 drugmakers alleging certain patents
US clears ExxonMobil deal, bars Pioneer ex-chief from board
AFP via Yahoo Finance· 12 hours agoUS antitrust authorities cleared ExxonMobil's acquisition of Pioneer Natural Resources under the...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 2 days agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...
FTC targets ‘junk patents’ on Ozempic, other top drugs
BioPharma Dive via Yahoo Finance· 2 days agoThe move broadens the antitrust regulator’s campaign against allegedly “improper or inaccurate”...
FTC Chief Says Tech Advancements Risk Healthcare Price Fixing
MedPage Today· 4 days agoAlgorithms make it possible for companies to fix prices without explicitly coordinating with one...
Meta, Microsoft and Google Aren’t Operating Like Monopolies At All
Forbes· 23 hours agoResponding back in 2022 to Meta’s planned acquisition of virtual reality start-up Within, FTC Chair ...
FTC Non-Compete Ban Could Impact Wirehouses and Banks More Than RIAs
WealthManagement.com· 1 day agoIn a statement about the final rule, FTC Chair Lina Khan said it would give American workers the...
Analysis of FTC Non-Compete Ban Legal Challenges: Does the Ban Pass Constitutional Muster? (And...
JD Supra· 1 day agoOn April 23, 2024, the Federal Trade Commission (FTC) voted in a 3 to 2 decision along party lines to adopt its Final Non-Compete Clause Rule (“Noncompete Rule”) banning post-employment ...
Williams-Sonoma must pay almost $3.2 million for violating FTC’s ‘Made in USA’ order - WTOP News
WTOP Washington· 6 days agoHome products retailer Williams-Sonoma will have to pay almost $3.2 million for violating a Federal...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 2 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...